{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:04:10Z","timestamp":1788667450153,"version":"build-2803163510"},"reference-count":138,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>An impaired healing response underlies diabetic foot wound chronicity, frequently translating to amputation, disability, and mortality. Diabetics suffer from underappreciated episodes of post-epithelization ulcer recurrence. Recurrence epidemiological data are alarmingly high, so the ulcer is considered in \u201cremission\u201d and not healed from the time it remains epithelialized. Recurrence may result from the combined effects of behavioral and endogenous biological factors. Although the damaging role of behavioral, clinical predisposing factors is undebatable, it still remains elusive in the identification of endogenous biological culprits that may prime the residual scar tissue for recurrence. Furthermore, the event of ulcer recurrence still waits for the identification of a molecular predictor. We propose that ulcer recurrence is deeply impinged by chronic hyperglycemia and its downstream biological effectors, which originate epigenetic drivers that enforce abnormal pathologic phenotypes to dermal fibroblasts and keratinocytes as memory cells. Hyperglycemia-derived cytotoxic reactants accumulate and modify dermal proteins, reduce scar tissue mechanical tolerance, and disrupt fibroblast-secretory activity. Accordingly, the combination of epigenetic and local and systemic cytotoxic signalers induce the onset of \u201cat-risk phenotypes\u201d such as premature skin cell aging, dysmetabolism, inflammatory, pro-degradative, and oxidative programs that may ultimately converge to scar cell demise. Post-epithelialization recurrence rate data are missing in clinical studies of reputed ulcer healing therapies during follow-up periods. Intra-ulcer infiltration of epidermal growth factor exhibits the most consistent remission data with the lowest recurrences during 12-month follow-up. Recurrence data should be regarded as a valuable clinical endpoint during the investigational period for each emergent healing candidate.<\/jats:p>","DOI":"10.3390\/ijms241210170","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T01:31:31Z","timestamp":1686879091000},"page":"10170","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Endogenous Biological Drivers in Diabetic Lower Limb Wounds Recurrence: Hypothetical Reflections"],"prefix":"10.3390","volume":"24","author":[{"given":"Jorge","family":"Berlanga-Acosta","sequence":"first","affiliation":[{"name":"Tissue Repair, Wound Healing and Cytoprotection Research Group, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Playa, Havana 10600, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Garcia-Ojalvo","sequence":"additional","affiliation":[{"name":"Tissue Repair, Wound Healing and Cytoprotection Research Group, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Playa, Havana 10600, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Guillen-Nieto","sequence":"additional","affiliation":[{"name":"Tissue Repair, Wound Healing and Cytoprotection Research Group, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Playa, Havana 10600, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ayala-Avila","sequence":"additional","affiliation":[{"name":"Tissue Repair, Wound Healing and Cytoprotection Research Group, Biomedical Research Direction, Center for Genetic Engineering and Biotechnology, Playa, Havana 10600, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc20-1913","article-title":"Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000\u20132015","volume":"44","author":"Cheng","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Liu, J., Ren, Z.H., Qiang, H., Wu, J., Shen, M., Zhang, L., and Lyu, J. (2020). Trends in the incidence of diabetes mellitus: Results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-09502-x"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.34172\/hpp.2020.18","article-title":"Prevalence and incidence of type 1 diabetes in the world: A systematic review and meta-analysis","volume":"10","author":"Mobasseri","year":"2020","journal-title":"Health Promot. Perspect."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K.B., Ostolaza, H., and Martin, C. (2020). Pathophysiology of Type 2 Diabetes Mellitus. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176275"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41574-020-0334-z","article-title":"Young-onset type 2 diabetes mellitus\u2014Implications for morbidity and mortality","volume":"16","author":"Magliano","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00125-022-05857-5","article-title":"Cardiovascular outcomes in type 1 and type 2 diabetes","volume":"66","author":"Rosengren","year":"2023","journal-title":"Diabetologia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tem.2020.01.007","article-title":"Chronic Diabetes Complications: The Need to Move beyond Classical Concepts","volume":"31","author":"Mauricio","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2337\/dbi20-0030","article-title":"Epigenetic Mechanisms in Diabetic Vascular Complications and Metabolic Memory: The 2020 Edwin Bierman Award Lecture","volume":"70","author":"Natarajan","year":"2021","journal-title":"Diabetes"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Deng, J.-Y., Wu, X.-Q., He, W.-J., Liao, X., Tang, M., and Nie, X.-Q. (2023). Targeting DNA methylation and demethylation in diabetic foot ulcers. J. Adv. Res.","DOI":"10.1016\/j.jare.2023.01.009"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4239\/wjd.v13.i1.27","article-title":"Management of diabetic foot ulcers and the challenging points: An endocrine view","volume":"13","author":"Aydemir","year":"2022","journal-title":"World J. Diabetes"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/dom.14840","article-title":"Global mortality of diabetic foot ulcer: A systematic review and meta-analysis of observational studies","volume":"25","author":"Chen","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2337\/dci22-0043","article-title":"Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers","volume":"46","author":"McDermott","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_13","first-page":"558","article-title":"Risk factors for diabetic foot ulcers: An Albanian retrospective study of inpatients with type 2 diabetes","volume":"26","author":"Pastore","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"929864","DOI":"10.3389\/fendo.2022.929864","article-title":"Predicting the Risk of Diabetic Foot Ulcers from Diabetics With Dysmetabolism: A Retrospective Clinical Trial","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db2022-02","article-title":"New Evidence-Based Therapies for Complex Diabetic Foot Wounds","volume":"2022","author":"Boulton","year":"2022","journal-title":"ADA Clin. Compend."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11010-022-04372-w","article-title":"Clinically relevant experimental rodent models of diabetic foot ulcer","volume":"477","author":"Rai","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"ref_17","first-page":"44","article-title":"Wound chronicity, impaired immunity and infection in diabetic patients","volume":"24","author":"Armstrong","year":"2022","journal-title":"MEDICC Rev."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Leal, E.C., and Carvalho, E. (2022). Heme Oxygenase-1 as Therapeutic Target for Diabetic Foot Ulcers. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231912043"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"573032","DOI":"10.3389\/fendo.2020.573032","article-title":"Cellular Senescence as the Pathogenic Hub of Diabetes-Related Wound Chronicity","volume":"11","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"120490","DOI":"10.1016\/j.lfs.2022.120490","article-title":"Mechanistic insights into glucose induced vascular epigenetic reprogramming in type 2 diabetes","volume":"298","author":"Dhawan","year":"2022","journal-title":"Life Sci."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bouly, M., Laborne, F.-X., Tourte, C., Henry, E., Penfornis, A., and Dardari, D. (2022). Post-healing follow-up study of patients in remission for diabetic foot ulcers Pied-REM study. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0268242"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/iwj.14017","article-title":"Influencing factors for the recurrence of diabetic foot ulcers: A meta-analysis","volume":"20","author":"Guo","year":"2023","journal-title":"Int. Wound J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic Foot Ulcers and Their Recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/iwj.13200","article-title":"Risk factors for the recurrence of diabetic foot ulcers among diabetic patients: A meta-analysis","volume":"16","author":"Huang","year":"2019","journal-title":"Int. Wound J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13047-020-0369-3","article-title":"Ulcer metastasis? Anatomical locations of recurrence for patients in diabetic foot remission","volume":"13","author":"Petersen","year":"2020","journal-title":"J. Foot Ankle Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/dme.13964","article-title":"Incidence and predictors of recurrent and other new diabetic foot ulcers: A retrospective cohort study","volume":"36","author":"Engberg","year":"2019","journal-title":"Diabet. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jss.2019.09.025","article-title":"Incidence and Risk Factors Associated with Ulcer Recurrence Among Patients With Diabetic Foot Ulcers Treated in a Multidisciplinary Setting","volume":"246","author":"Hicks","year":"2020","journal-title":"J. Surg. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12020-020-02431-0","article-title":"Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: A 10-year retrospective cohort study","volume":"71","author":"Gazzaruso","year":"2021","journal-title":"Endocrine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3892\/mmr.2016.4822","article-title":"Transcriptomic study of high\u2013glucose effects on human skin fibroblast cells","volume":"13","author":"Pang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Su\u00e1rez, R., Chapela, S.P., \u00c1lvarez-C\u00f3rdova, L., Bautista-Valarezo, E., Sarmiento-Andrade, Y., Verde, L., Frias-Toral, E., and Sarmo, G. (2023). Epigenetics in Obesity and Diabetes Mellitus: New Insights. Nutrients, 15.","DOI":"10.3390\/nu15040811"},{"key":"ref_31","first-page":"1","article-title":"Epigenetic regulation in metabolic diseases: Mechanisms and advances in clinical study","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-020-00896-4","article-title":"The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus","volume":"12","author":"Ahmed","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Cugalj, K.B., Trebusak, P.K., Kovac, J., Sket, R., Jenko, B.B., Tesovnik, T., Debelijak, M., Batelino, T., and Bratina, N. (2022). The Role of Epigenetic Modifications in Late Complications in Type 1 Diabetes. Genes, 13.","DOI":"10.3390\/genes13040705"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ramteke, P., Deb, A., Shepal, V., and Bhat, M.K. (2019). Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality. Cancers, 11.","DOI":"10.3390\/cancers11091402"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.semcancer.2020.11.019","article-title":"Effect of non-enzymatic glycosylation in the epigenetics of cancer","volume":"83","author":"Rehman","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s42255-020-0231-8","article-title":"DNA methylation mediates development of HbA1c-associated complications in type 1 diabetes","volume":"2","author":"Chen","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"100774","DOI":"10.1016\/j.jbc.2021.100774","article-title":"Genetic and environmental factors regulate the type 1 diabetes gene CTSH via differential DNA methylation","volume":"296","author":"Ye","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.4161\/15592294.2014.967584","article-title":"Genome-wide DNA methylation analysis identifies a metabolic memory profile in patient-derived diabetic foot ulcer fibroblasts","volume":"9","author":"Park","year":"2014","journal-title":"Epigenetics"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"807413","DOI":"10.3389\/fphar.2021.807413","article-title":"Epigenetics and Beyond: Targeting Histone Methylation to Treat Type 2 Diabetes Mellitus","volume":"12","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCRESAHA.115.306424","article-title":"Differential Promoter Methylation of Macrophage Genes Is Associated with Impaired Vascular Growth in Ischemic Muscles of Hyperlipidemic and Type 2 Diabetic Mice: Genome-Wide Promoter Methylation Study","volume":"117","author":"Babu","year":"2015","journal-title":"Circ Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jdiacomp.2014.11.015","article-title":"Genetic and epigenetic alterations in Toll like receptor 2 and wound healing impairment in type 2 diabetes patients","volume":"29","author":"Singh","year":"2015","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jid.2020.10.023","article-title":"Transient High Glucose Causes Persistent Vascular Dysfunction and Delayed Wound Healing by the DNMT1-Mediated Ang-1\/NF-kappaB Pathway","volume":"141","author":"Zhao","year":"2021","journal-title":"J. Invest Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"20392","DOI":"10.1002\/jcp.28640","article-title":"Generation of a nitric oxide signaling pathway in mesenchymal stem cells promotes endothelial lineage commitment","volume":"234","author":"Bandara","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/glycob\/cwab011","article-title":"Recent advances in histone glycation: Emerging role in diabetes and cancer","volume":"31","author":"Mir","year":"2021","journal-title":"Glycobiology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-09192-z","article-title":"Reversible histone glycation is associated with disease-related changes in chromatin architecture","volume":"10","author":"Zheng","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Singh, K., Rustagi, Y., Abouhashem, A.S., Tabasum, S., Verma, P., Hernandez, E., Pal, D., Khona, D.K., Mohanty, S.K., and Kumar, M. (2022). Genome-wide DNA hypermethylation opposes healing in patients with chronic wounds by impairing epithelial-mesenchymal transition. J. Clin. Investig., 132.","DOI":"10.1172\/JCI157279"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.omtn.2021.03.015","article-title":"The progress, prospects, and challenges of the use of non-coding RNA for diabetic wounds","volume":"24","author":"Li","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1084\/jem.20081188","article-title":"Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia","volume":"205","author":"Brasacchio","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"989844","DOI":"10.3389\/fendo.2022.989844","article-title":"Epigenetic basis of diabetic vasculopathy","volume":"13","author":"Bhamidipati","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/iwj.13070","article-title":"The role of microRNAs in the healing of diabetic ulcers","volume":"16","author":"Goodarzi","year":"2019","journal-title":"Int. Wound J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tcm.2018.08.002","article-title":"MicroRNAs in diabetic wound healing: Pathophysiology and therapeutic opportunities","volume":"29","author":"Ozdemir","year":"2018","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"103323","DOI":"10.1016\/j.drudis.2022.07.008","article-title":"Exosome-cargoed microRNAs: Potential therapeutic molecules for diabetic wound healing","volume":"27","author":"Lou","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1002\/jcp.30485","article-title":"MiR equal than others: MicroRNA enhancement for cutaneous wound healing","volume":"236","author":"Ross","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2337\/db17-1238","article-title":"MicroRNA-129 and -335 Promote Diabetic Wound Healing by Inhibiting Sp1-Mediated MMP-9 Expression","volume":"67","author":"Wang","year":"2018","journal-title":"Diabetes"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.2337\/db12-0145","article-title":"The role of microRNA-146a in the pathogenesis of the diabetic wound-healing impairment: Correction with mesenchymal stem cell treatment","volume":"61","author":"Xu","year":"2012","journal-title":"Diabetes"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.2147\/DMSO.S376292","article-title":"Increased Expression of miR-155 in Peripheral Blood and Wound Margin Tissue of Type 2 Diabetes Mellitus Patients Associated with Diabetic Foot Ulcer","volume":"15","author":"Xu","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_57","first-page":"13416","article-title":"Quantification of the differential expression levels of microRNA-203 in different degrees of diabetic foot","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.2147\/DMSO.S326066","article-title":"Enhanced Expression of miR-34c in Peripheral Plasma Associated with Diabetic Foot Ulcer in Type 2 Diabetes Patients","volume":"14","author":"Wu","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/iwj.13655","article-title":"Long non-coding RNAs in diabetic wound healing: Current research and clinical relevance","volume":"19","author":"Kuai","year":"2022","journal-title":"Int. Wound J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1005307","DOI":"10.3389\/fimmu.2022.1005307","article-title":"Exosomal ncRNAs: The pivotal players in diabetic wound healing","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Pirola, L. (2020). Epigenetics of Diabetic Microvascular Disease. Microvasc. Dis. Diabetes, 45\u201357.","DOI":"10.1002\/9781119309642.ch4"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1573399817666210920102318","article-title":"The Role of Oxidative Stress, Inflammation, and Advanced Glycation End Product in Skin Manifestations of Diabetes Mellitus","volume":"18","author":"Legiawati","year":"2022","journal-title":"Curr. Diabetes Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s11033-022-08107-4","article-title":"Role of fibroblast plasticity and heterogeneity in modulating angiogenesis and healing in the diabetic foot ulcer","volume":"50","author":"Rai","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Liechty, C., Hu, J., Zhang, L., Liechty, K.W., and Xu, J. (2020). Role of microRNA-21 and Its Underlying Mechanisms in Inflammatory Responses in Diabetic Wounds. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093328"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e09571","DOI":"10.1016\/j.heliyon.2022.e09571","article-title":"Skin accumulation of advanced glycation end products and cardiovascular risk in Korean patients with type 2 diabetes mellitus","volume":"8","author":"Choi","year":"2022","journal-title":"Heliyon"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Zheng, W., Li, H., Go, Y., Chan, X.H., Huang, Q., and Wu, J. (2022). Research Advances on the Damage Mechanism of Skin Glycation and Related Inhibitors. Nutrients, 14.","DOI":"10.3390\/nu14214588"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8852759","article-title":"The Role of Oxidative Stress and Antioxidants in Diabetic Wound Healing","volume":"2021","author":"Deng","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_69","first-page":"1","article-title":"Dermal fibroblasts cultured from donors with type 2 diabetes mellitus retain an epigenetic memory associated with poor wound healing responses","volume":"11","author":"Tobin","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Miwa, S., Kashyap, S., Chini, E., and von Zglinicki, T. (2022). Mitochondrial dysfunction in cell senescence and aging. J. Clin. Investig., 132.","DOI":"10.1172\/JCI158447"},{"key":"ref_71","first-page":"E268","article-title":"Mitochondrial dysfunction in type 2 diabetes mellitus: An organ-based analysis","volume":"316","author":"Pinti","year":"2019","journal-title":"Am. J. Physiol. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-2649-z","article-title":"Mitochondria in skin health, aging, and disease","volume":"11","author":"Sreedhar","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1096\/fj.201801059","article-title":"Differentiation of diabetic foot ulcer-derived induced pluripotent stem cells reveals distinct cellular and tissue phenotypes","volume":"33","author":"Kashpur","year":"2018","journal-title":"FASEB J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13619-022-00141-8","article-title":"Mitochondrial fragmentation and ROS signaling in wound response and repair","volume":"11","author":"Xu","year":"2022","journal-title":"Cell Regen."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e2203308","DOI":"10.1002\/advs.202203308","article-title":"Microenvironment-Based Diabetic Foot Ulcer Nanomedicine","volume":"10","author":"Huang","year":"2022","journal-title":"Adv. Sci."},{"key":"ref_76","unstructured":"Cabal, M.C., Gonz\u00e1lez, D.E., Berlanga-Acosta, J., Zayas, D., Herrera, L., Lopez-Saura, P., Guillen, G., Baldomero, J., Delgado, C.G., and Gonzalez, L.J. (2014). Quantitative Studies of the Evolution of Diabetic Foot Lesions under EGF Treatment by Magnetic Resonance Imaging. J. Radiol. Res. Pract., 2014."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Khalid, M., Petroianu, G., and Adem, A. (2022). Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives. Biomolecules, 12.","DOI":"10.3390\/biom12040542"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jphotobiol.2018.07.032","article-title":"Mitochondrial dynamics (fission and fusion) and collagen production in a rat model of diabetic wound healing treated by photobiomodulation: Comparison of 904 nm laser and 850 nm light-emitting diode (LED)","volume":"187","author":"Tim","year":"2018","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1111\/jcmm.14316","article-title":"Diversity of dermal fibroblasts as major determinant of variability in cell reprogramming","volume":"23","author":"Sacco","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Kirk, T., Ahmed, A., and Rognoni, E. (2021). Fibroblast Memory in Development, Homeostasis and Disease. Cells, 10.","DOI":"10.3390\/cells10112840"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/wrr.12794","article-title":"Regenerative and protective effects of calcium silicate on senescent fibroblasts induced by high glucose","volume":"28","author":"Li","year":"2020","journal-title":"Wound Repair Regen."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/term.3246","article-title":"A review of diabetic wound models-Novel insights into diabetic foot ulcer","volume":"15","author":"Phang","year":"2021","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Maitra, S., and Dutta, D. (2020). Downregulation of Hexose Sugar Metabolism in Diabetes Decreases the Rate of Wound Healing, Academic Press.","DOI":"10.1016\/B978-0-12-816413-6.00013-7"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s13105-021-00823-y","article-title":"Metformin reverses the effects of high glucose on human dermal fibroblasts of aged skin via downregulating RELA\/p65 expression","volume":"77","author":"Soydas","year":"2021","journal-title":"J. Physiol. Biochem."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Vuj\u010di\u0107, S., Kotur-Stevuljevi\u0107, J., Veki\u0107, J., Perovi\u0107-Blagojevi\u0107, I., Stefanovi\u0107, T., Ili\u0107-Mijailovi\u0107, S., Uzelac, B.K., Bosic, S., Antonic, T., and Guzonjic, A. (2022). Oxidative Stress and Inflammatory Biomarkers in Patients with Diabetic Foot. Medicina, 58.","DOI":"10.3390\/medicina58121866"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2337\/db20-0188","article-title":"Integrated Skin Transcriptomics and Serum Multiplex Assays Reveal Novel Mechanisms of Wound Healing in Diabetic Foot Ulcers","volume":"69","author":"Theocharidis","year":"2020","journal-title":"Diabetes"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Fang, W.-C., and Lan, C.-C.E. (2023). The Epidermal Keratinocyte as a Therapeutic Target for Management of Diabetic Wounds. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054290"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.it.2021.10.005","article-title":"Baby\u2019s skin bacteria: First impressions are long-lasting","volume":"42","author":"Dhariwala","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bjd.13243","article-title":"\u2018Memory\u2019 of the stratum corneum: Exploration of the epidermis\u2019 past","volume":"171","author":"Haftek","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jdermsci.2023.01.007","article-title":"Investigation of the keratinocyte transcriptome altered in high-glucose environment: An in-vitro model system for precision medicine","volume":"109","author":"Chen","year":"2023","journal-title":"J. Dermatol. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.molmed.2020.04.004","article-title":"Metabolic Pathways That Control Skin Homeostasis and Inflammation","volume":"26","author":"Cibrian","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref_92","first-page":"430","article-title":"The role of keratinocyte function on the defected diabetic wound healing","volume":"11","author":"Mansoub","year":"2021","journal-title":"Int. J. Burns Trauma."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.trsl.2015.11.002","article-title":"High-glucose environment increased thrombospondin-1 expression in keratinocytes via DNA hypomethylation","volume":"169","author":"Lan","year":"2016","journal-title":"Transl. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1073\/pnas.1814097116","article-title":"Human skin long noncoding RNA WAKMAR1 regulates wound healing by enhancing keratinocyte migration","volume":"116","author":"Li","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"109831","DOI":"10.1016\/j.diabres.2022.109831","article-title":"AGEs-induced MMP-9 activation mediated by Notch1 signaling is involved in impaired wound healing in diabetic rats","volume":"186","author":"Zhu","year":"2022","journal-title":"Diabetes Res. Clin. Pr."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/cen.13047","article-title":"alpha-ketoglutarate is associated with delayed wound healing in diabetes","volume":"85","author":"Tan","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"676403","DOI":"10.3389\/fendo.2021.676403","article-title":"c-Myc Upregulated by High Glucose Inhibits HaCaT Differentiation by S100A6 Transcriptional Activation","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9440(10)62953-7","article-title":"Molecular pathogenesis of chronic wounds: The role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing","volume":"167","author":"Stojadinovic","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_99","first-page":"1","article-title":"Keratinocyte Function in Normal and Diabetic Wounds and Modulation by FOXO1","volume":"2020","author":"Wang","year":"2020","journal-title":"J. Diabetes Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e3160","DOI":"10.1002\/dmrr.3160","article-title":"Global recurrence rates in diabetic foot ulcers: A systematic review and meta-analysis","volume":"35","author":"Fu","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/dmrr.2696","article-title":"IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes","volume":"32","author":"Bus","year":"2016","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"6320514","DOI":"10.1155\/2020\/6320514","article-title":"The Role of Recombinant Proteins and Growth Factors in the Management of Diabetic Foot Ulcers: A Systematic Review of Randomized Controlled Trials","volume":"2020","author":"Mahdipour","year":"2020","journal-title":"J. Diabetes Res."},{"key":"ref_103","first-page":"1","article-title":"A narrative review on Epidermal Growth Factor (EGF) intralesional infiltrations for diabetic complex wounds: The rational of an innovative delivery route","volume":"7","author":"Fernandez","year":"2022","journal-title":"Vasc. Dis. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2000260","DOI":"10.1002\/adtp.202000260","article-title":"Recombinant Human Epidermal Growth Factor\/Quatsome Nanoconjugates: A Robust Topical Delivery System for Complex Wound Healing","volume":"4","author":"Santana","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.37757\/MR2020.V22.N3.7","article-title":"Epidermal Growth Factor in Healing Diabetic Foot Ulcers: From Gene Expression to Tissue Healing and Systemic Biomarker Circulation","volume":"22","year":"2020","journal-title":"MEDICC Rev."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Matoori, S., Veves, A., and Mooney, D.J. (2021). Advanced bandages for diabetic wound healing. Sci. Transl. Med., 13.","DOI":"10.1126\/scitranslmed.abe4839"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Zidari\u010d, T., Kleinschek, K.S., Maver, U., and Maver, T. (2023). Function-Oriented Bioengineered Skin Equivalents: Continuous Development Towards Complete Skin Replication, Springer International Publishing.","DOI":"10.1007\/978-3-031-21298-7"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s44222-023-00036-6","article-title":"Bioreactors for engineering patient-specific tissue grafts","volume":"1","author":"Sarkar","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"212738","DOI":"10.1016\/j.bioadv.2022.212738","article-title":"Cell-based dressings: A journey through chronic wound management","volume":"135","author":"Heras","year":"2022","journal-title":"Biomater. Adv."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"101717","DOI":"10.1016\/j.tice.2021.101717","article-title":"Tissue engineering in dermatology\u2014From lab to market","volume":"74","author":"Nilforoushzadeh","year":"2022","journal-title":"Tissue Cell."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jtv.2019.04.001","article-title":"The efficacy of negative pressure wound therapy for diabetic foot ulcers: A systematised review","volume":"28","author":"Wynn","year":"2019","journal-title":"J. Tissue Viability"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13018-023-03561-7","article-title":"Vacuum-assisted closure versus conventional dressing in necrotizing fasciitis: A systematic review and meta-analysis","volume":"18","author":"Zhang","year":"2023","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2337\/diacare.21.5.822","article-title":"Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study","volume":"21","author":"Wieman","year":"1998","journal-title":"Diabetes Care"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Bui, T.Q., Bui, Q.V.P., N\u00e9meth, D., Hegyi, P., Szak\u00e1cs, Z., Rumbus, Z., Toth, B., Emri, G., Parniczky, A., and Sarlos, P. (2019). Epidermal Growth Factor is Effective in the Treatment of Diabetic Foot Ulcers: Meta-Analysis and Systematic Review. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16142584"},{"key":"ref_115","first-page":"186","article-title":"A phase III study to evaluate the safety and efficacy of recombinant human epidermal growth factor (REGEN-D\u2122 150) in healing diabetic foot ulcers","volume":"18","author":"Viswanathan","year":"2006","journal-title":"Wounds"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/iwj.13789","article-title":"A multicenter clinical trial evaluating the durability of diabetic foot ulcer healing in ulcers treated with topical oxygen and standard of care versus standard of care alone 1 year post healing","volume":"19","author":"Kupcella","year":"2022","journal-title":"Int. Wound J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.2337\/diacare.26.6.1856","article-title":"Human epidermal growth factor enhances healing of diabetic foot ulcers","volume":"26","author":"Tsang","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.sap.0000198731.12407.0c","article-title":"Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers","volume":"56","author":"Hong","year":"2006","journal-title":"Ann. Plast. Surg."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diabres.2018.06.002","article-title":"Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial","volume":"142","author":"Park","year":"2018","journal-title":"Diabetes Res. Clin. Pr."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1742-481X.2009.00594.x","article-title":"The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: The preliminary results","volume":"6","author":"Quynh","year":"2009","journal-title":"Int. Wound J."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1742-481X.2009.00641.x","article-title":"Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: Multicenter, randomised, placebo-controlled, double-blind study","volume":"6","author":"Diaz","year":"2009","journal-title":"Int. Wound J."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/wrr.12236","article-title":"Response to Uzun G","volume":"22","year":"2014","journal-title":"Wound Repair Regen."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"38","DOI":"10.25083\/2559.5555\/7.1.7","article-title":"The effect of human recombinant epidermal growth factor in the treatment of diabetic foot ulcers","volume":"7","author":"Okut","year":"2022","journal-title":"J. Clin. Investig. Surg."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Yera-Alos, I.B., Alonso-Carbonell, L., Valenzuela-Silva, C.M., Tuero-Iglesias, A.D., Moreira-Martinez, M., Marrero-Rodriguez, I., Lopez-Mola, E., and Lopez-Saura, P.A. (2013). Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers. BMC Pharmacol. Toxicol., 14.","DOI":"10.1186\/2050-6511-14-44"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Yera-Alos, I.B., A L\u00f3pez-Saura, P., Valenzuela-Silva, C., Gonz\u00e1lez-D\u00edaz, O., Del R\u00edo-Mart\u00edn, A., Berlanga-Acosta, J., Fernandez-Montequin, J.I., Acevedo-Castro, B., Lopez-Mola, E., and Herrera-martinez, L. (2013). Medical Practice Confirms Clinical Trial Results of the Use of Intralesional Human Recombinant Epidermal Growth Factor in Advanced Diabetic Foot Ulcers. Adv. Pharmacoepidemiol. Drug Saf., 2.","DOI":"10.4172\/2167-1052.1000128"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.jfas.2018.08.041","article-title":"The Long-Term Outcomes Following the Application of Intralesional Epidermal Growth Factor in Patients with Diabetic Foot Ulcers","volume":"58","author":"Kahraman","year":"2019","journal-title":"J. Foot Ankle Surg."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1524-475x.2000.00162.x","article-title":"Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: An open-label clinical evaluation of efficacy","volume":"8","author":"Embil","year":"2000","journal-title":"Wound Repair Regen."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1524-475X.1999.00335.x","article-title":"Sampson AR, Schwab BH. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: A combined analysis of four randomized studies","volume":"7","author":"Smiell","year":"1999","journal-title":"Wound Repair Regen."},{"key":"ref_129","first-page":"83","article-title":"Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: A randomized, controlled trial","volume":"27","author":"Ma","year":"2015","journal-title":"Wounds"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/diacare.24.2.290","article-title":"Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: A prospective randomized multicenter clinical trial","volume":"24","author":"Veves","year":"2001","journal-title":"Diabetes Care"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diacare.26.6.1701","article-title":"Dermagraft Diabetic Foot Ulcer Study G. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: Results of a prospective randomized trial","volume":"26","author":"Marston","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/iwj.12566","article-title":"Treatment of chronic diabetic lower extremity ulcers with advanced therapies: A prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost","volume":"13","author":"Zelen","year":"2016","journal-title":"Int. Wound J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.wndm.2013.10.008","article-title":"Dehydrated human amnion\/chorion membrane allografts in patients with chronic diabetic foot ulcers: A long-term follow-up study","volume":"4","author":"Zelen","year":"2014","journal-title":"Wound Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/dc07-2196","article-title":"Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: A multicenter randomized controlled trial","volume":"31","author":"Blume","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/S0140-6736(05)67695-7","article-title":"Diabetic Foot Study C. Negative pressure wound therapy after partial diabetic foot amputation: A multicentre, randomised controlled trial","volume":"366","author":"Armstrong","year":"2005","journal-title":"Lancet"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PRS.0000000000000275","article-title":"Effectiveness and safety of negative-pressure wound therapy for diabetic foot ulcers: A meta-analysis","volume":"134","author":"Zhang","year":"2014","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/TCRM.S131193","article-title":"Evaluation of negative-pressure wound therapy for patients with diabetic foot ulcers: Systematic review and meta-analysis","volume":"13","author":"Liu","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5312\/wjo.v6.i4.387","article-title":"Management of negative pressure wound therapy in the treatment of diabetic foot ulcers","volume":"6","author":"Meloni","year":"2015","journal-title":"World J. Orthop."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/12\/10170\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:55:35Z","timestamp":1760126135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/12\/10170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":138,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["ijms241210170"],"URL":"https:\/\/doi.org\/10.3390\/ijms241210170","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]}}}